mci 225 has been researched along with ondansetron in 1 studies
| Studies (mci 225) | Trials (mci 225) | Recent Studies (post-2010) (mci 225) | Studies (ondansetron) | Trials (ondansetron) | Recent Studies (post-2010) (ondansetron) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 3,380 | 1,216 | 994 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, J; Inomata, Y; Saito, K | 1 |
1 other study(ies) available for mci 225 and ondansetron
| Article | Year |
|---|---|
The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Biguanides; Male; Norepinephrine; Ondansetron; Piperazines; Psychotropic Drugs; Pyrimidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists | 2001 |